Shared Decision Making at Scale – Why It Matters to aiomics

At aiomics, our mission is to give healthcare providers back time, focus, and confidence—so they can practice closer to their calling and build stronger connections with their patients. Few areas reflect this mission more clearly than Shared Decision Making (SDM): the idea that treatment choices should be made together, with medical expertise and patient preferences carrying equal weight.

This year, we took an important step in advancing this conversation. Together with Roche’s Independent Patient Council, medical experts, patient representatives, and Google, a comprehensive white paper was created on how AI can finally make Shared Decision Making possible at scale . The lead author was our CEO and co-founder, Dr. Sven Jungmann, who brings both his background as a physician and his experience in AI-driven healthcare innovation to the table.

The white paper shows how AI can prepare information in a way that patients can understand, help them articulate their priorities, and ensure physicians have structured, evidence-based insights at hand. Done right, this doesn’t replace the human interaction—it strengthens it. The outcome is more time for meaningful conversations, fewer misunderstandings, and decisions that align better with what really matters to patients.

For us at Aiomics, this work is not an isolated project. It ties directly into what we build every day: a co-pilot that captures, validates, and structures the data around care, so that providers are freed from clerical burdens and can focus on the conversations that count.

The picture from the Roche Summer Summit in Grenzach-Wyhlen, where Dr. Jungmann sat in the middle of a panel of patients, providers, and experts, reflects exactly what we believe in: healthcare is strongest when people with different perspectives sit down together and shape solutions collectively.

Shared Decision Making is more than a concept—it is a practical way to make care more human. We are proud to contribute to this dialogue and will continue to invest our time and expertise to ensure that technology strengthens the bond between providers and patients, rather than standing in its way.

The whitepaper can be found here [German].

Previous
Previous

Aiomics Joins the Norrsken Evolve Programme